FDA Approves Illumina's TruSight Oncology Comprehensive Assay, Now Offered by PreCheck Health Services as "SolidTumorCheck+" -- A Breakthrough in Precision Oncology
ILMNIllumina(ILMN) Prnewswire·2024-09-09 21:09

MIAMI, Sept. 9, 2024 /PRNewswire/ -- The FDA has granted approval on Illumina's TruSight Oncology Comprehensive Assay, marking a transformative milestone in cancer diagnostics. This innovative in vitro diagnostic (IVD) kit is the first of its kind, offering distributable comprehensive genomic profiling (CGP) with pan-cancer companion diagnostic claims. PreCheck Health Services is excited to introduce this test under the name SolidTumorCheck+, marking the beginning of a new phase in precision oncology and pa ...